|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,380,000 |
Market
Cap: |
202.44(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$11.6 - $15.13 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
150,600 |
504,050 |
1,186,050 |
Total Buy Value |
$0 |
$1,950,226 |
$6,240,948 |
$13,627,905 |
Total People Bought |
0 |
1 |
2 |
4 |
Total Buy Transactions |
0 |
3 |
13 |
41 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nielsen Ulrik B. |
SVP and CSO |
|
2013-04-24 |
4 |
AS |
$5.40 |
$56,566 |
D/D |
(10,483) |
176,811 |
|
- |
|
Nielsen Ulrik B. |
SVP and CSO |
|
2013-04-24 |
4 |
OE |
$2.19 |
$22,958 |
D/D |
10,483 |
187,294 |
|
- |
|
Sinskey Anthony J |
Director |
|
2013-04-24 |
4 |
OE |
$2.19 |
$32,850 |
D/D |
15,000 |
388,743 |
|
- |
|
Fehr Gordon J. |
Director |
|
2013-04-15 |
4 |
AS |
$6.04 |
$90,645 |
D/D |
(15,000) |
190,143 |
|
- |
|
Fehr Gordon J. |
Director |
|
2013-04-15 |
4 |
OE |
$2.19 |
$32,850 |
D/D |
15,000 |
205,143 |
|
- |
|
Niyikiza Clet M. |
EVP of Development |
|
2013-02-05 |
4 |
OE |
$2.12 |
$87,995 |
D/D |
41,507 |
141,507 |
|
- |
|
Mulroy Robert J. |
President and CEO |
|
2013-01-04 |
4 |
A |
$0.00 |
$0 |
I/I |
58,290 |
906,544 |
|
- |
|
Mulroy Robert J. |
President and CEO |
|
2013-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,443 |
848,254 |
|
- |
|
Crocker Gary L |
Director |
|
2012-12-19 |
5 |
GA |
$0.00 |
$0 |
I/I |
69,030 |
2,471,271 |
|
- |
|
Crocker Gary L |
Director |
|
2012-12-19 |
5 |
GD |
$0.00 |
$0 |
I/I |
129,090 |
2,441,241 |
|
- |
|
Niyikiza Clet M. |
EVP of Development |
|
2012-12-18 |
4 |
OE |
$2.12 |
$212,000 |
D/D |
100,000 |
100,000 |
|
- |
|
Porter Michael E |
Director |
|
2012-12-17 |
4 |
OE |
$2.19 |
$32,850 |
D/D |
15,000 |
277,865 |
|
- |
|
Khan Fazal R. |
SVP of Manufacturing |
|
2012-12-17 |
4 |
S |
$6.41 |
$160,343 |
D/D |
(25,000) |
0 |
|
- |
|
Khan Fazal R. |
SVP of Manufacturing |
|
2012-12-17 |
4 |
OE |
$1.71 |
$42,750 |
D/D |
25,000 |
25,000 |
|
- |
|
Mendelsohn John |
Director |
|
2012-12-14 |
4 |
B |
$6.63 |
$33,145 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
Khan Fazal R. |
SVP of Manufacturing |
|
2012-12-13 |
4 |
S |
$6.73 |
$168,320 |
D/D |
(25,000) |
0 |
|
- |
|
Khan Fazal R. |
SVP of Manufacturing |
|
2012-12-13 |
4 |
OE |
$1.71 |
$42,750 |
D/D |
25,000 |
25,000 |
|
- |
|
Crocker Gary L |
Director |
|
2012-12-13 |
4 |
B |
$6.77 |
$247,215 |
I/I |
36,500 |
2,531,331 |
2.1 |
- |
|
Porter Michael E |
Director |
|
2012-12-10 |
4 |
B |
$6.08 |
$60,800 |
D/D |
10,000 |
262,865 |
2.39 |
- |
|
Nielsen Ulrik B. |
SVP and CSO |
|
2012-12-03 |
4 |
S |
$7.37 |
$552,750 |
D/D |
(75,000) |
176,811 |
|
- |
|
Crocker Gary L |
Director |
|
2012-09-14 |
4 |
B |
$8.32 |
$539,609 |
I/I |
64,800 |
2,494,831 |
2.1 |
- |
|
Sinskey Anthony J |
Director |
|
2012-09-07 |
5 |
GA |
$0.00 |
$0 |
I/I |
32,776 |
373,743 |
|
- |
|
Sinskey Anthony J |
Director |
|
2012-09-07 |
5 |
GA |
$0.00 |
$0 |
D/D |
16,185 |
340,967 |
|
- |
|
Sinskey Anthony J |
Director |
|
2012-09-07 |
5 |
GD |
$0.00 |
$0 |
I/I |
81,736 |
324,782 |
|
- |
|
Quigley James H. |
Director |
|
2012-08-24 |
4 |
B |
$7.50 |
$94,360 |
D/D |
12,500 |
12,500 |
2.39 |
- |
|
410 Records found
|
|
Page 15 of 17 |
|
|